๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance

โœ Scribed by Theresa Reiter, Oliver Ritter, Martin R Prince, Peter Nordbeck, Christoph Wanner, Eike Nagel, Wolfgang Rudolf Bauer


Book ID
119905710
Publisher
BioMed Central
Year
2012
Tongue
English
Weight
522 KB
Volume
14
Category
Article
ISSN
1097-6647

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The incidence of nephrogenic systemic fi
โœ Anna Lisa Crowley; Han W Kim; Michele Parker; Deneen Spatz; Brenda Hayes; Lubna ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› BioMed Central ๐ŸŒ English โš– 132 KB

The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance is low (0.026% overall and 1.274% in those subjects with CKD Stage 5 on hemodialysis).

Gadolinium-enhanced magnetic resonance i
โœ Constantina Chrysochou; David L. Buckley; Paul Dark; Alistair Cowie; Philip A. K ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 212 KB

## Abstract ## Purpose To examine the positive reporting bias regarding the link with gadolinium (Gd) exposure and nephrogenic systemic fibrosis (NSF) in patients with renal impairment. This link has impacted strongly the international radiology safety guidelines. We believe that positive reportin